1. Targeting Clusterin Induces Apoptosis, Reduces Growth Ability and Invasion and Mediates Sensitivity to Chemotherapy in Human Osteosarcoma Cells
   Xiaohui Wang et al, 2020, Current Pharmaceutical Biotechnology CrossRef
2. Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate
   Shiho Morita-Tokuhiro et al, 2016, Cancers CrossRef
3. Paradigm Shift in Radiation Biology/Radiation Oncology—Exploitation of the “H2O2 Effect” for Radiotherapy Using Low-LET (Linear Energy Transfer) Radiation such as X-rays and High-Energy Electrons
   Yasuhiro Ogawa, 2016, Cancers CrossRef
4. Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging
   Shin Yaogawa et al, 2015, Cancers CrossRef
5. Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer—Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?
   Naoya Hayashi et al, 2016, Cancers CrossRef
6. Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer
   Yasuhiro Ogawa et al, 2015, Cancers CrossRef
7. A Case of Osteosarcoma of the Temporal Region Arising in Fibrous Dysplasia
   Yusuke Kiyokawa et al, 2018, Practica oto-rhino-laryngologica. Suppl. CrossRef